Fundraising FoxBroadview Ventures — 2012 Investments
5 investments dated 2012 · listed companies and verified rows first · show all
Capricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy.
BiotechMedical DevicesLos Angeles, US
Linda Marban(President and Chief Executive Officer, Director)inLinda Marbán, Ph.D.(Chief Executive Officer and Director; co-founder of Capricor, Inc.)Rachel Smith(Executive Officer)inKaren Krasney(Executive Officer)inAnthony Bergmann(Executive Officer)Andrew Hamer(Executive Officer)in
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
BiotechDeep TechMedical Devices
Antti Vuolanto(CEO)in
Co-investorsInnovestor Ventures
InfoBionic.Ai develops a remote cardiac monitoring platform called MoMe ARC that combines AI-powered ECG analysis, interchangeable biosensors, and clinical analytics to enable hospital-grade cardiac telemetry outside traditional hospital settings.
AI & Machine LearningHealthtechMedical DevicesLowell, US
Steven Wasserman(Executive Officer)Nancy Briefs(Executive Officer, Director)
BoardCarl Berke(Director)Caleb Winder(Director)inAl Wiegman(Director)Hamid Tabatabaie(Director)
Co-investorsExcel Venture ManagementHealthtech CapitalKeiretsu Forum
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Laurantis PharmaViridian Therapeutics (Formerly MiRagen Therapeutics)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.